https://www.selleckchem.com/pr....oducts/tegatrabetan.
3%) patients. According to the Chi-square test, patient distribution was 21 in HER2-positive HP-negative group, 20 in HER2-positive HP-positive group, 100 in HER2-negative HP-negative group, and 67 in HER2-negative HP-positive group. No correlation was found between HP and HER2 status (P = 0.314). HP positivity had significant effect on median overall survival (27.4 vs. 12.9 months, P = 0.046). Our results suggest that there is no relationship between HP infection and HER2 status in patients with GC. Our results suggest that there
Like
Comment
Share
